<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03581110</url>
  </required_header>
  <id_info>
    <org_study_id>UMannheim</org_study_id>
    <nct_id>NCT03581110</nct_id>
  </id_info>
  <brief_title>CODP Imaging From a Dose Perspective</brief_title>
  <official_title>CODP Imaging From a Dose Perspective - Effective Organ Doses of a Combined Inspiration-expiration Protocol on a 3rd Generation Dual-source CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universit채tsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universit채tsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The noncontrast-enhanced chest computed tomography (CT) is an emerging diagnostical tool in
      patient with chronic obstructive pulmonary disease (COPD). As shown in previous studies and
      pointed out by the Fleischner society, an additional scan in expiration reflects the
      pathophysiology of this complex disease better and extends the clinical information of the
      CT.

      Nevertheless, this scan is leading to an increase in radiation dose. But currently it is
      unclear if this increased radiation dose is proportional to the additional clinical value
      when compared to inspiration-only protocols. Therefore, the aim of this study was to compare
      the organ specific radiation doses of a combined inspiration-expiration CT on a 3rd
      generation dual-source scanner with noncontrast-enhanced chest CTs of two clinical routine
      scanners. Therefore, the radiation doses of nearly 2000 chest CTs have been evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>organ specific radiation doses</measure>
    <time_frame>The organ dose calculations have been performed retrospectively. Therefore, the time frame is variable. The time set for the final outcome calculations was September 2017. Therefore, the time frame varies between 3 years and 1 week.</time_frame>
    <description>Organ specific radiation doses of 17 individual organs</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">1957</enrollment>
  <condition>Radiation</condition>
  <arm_group>
    <arm_group_label>16-slice CT scanner</arm_group_label>
    <description>1426 patients that have received a noncontrast-enhanced chest CT on our 16-slice clinical routine CT scanner in inspiration only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd generation dual-source CT</arm_group_label>
    <description>320 patients that have received a noncontrast-enhanced chest CT on our second generation dual-source CT scanner in inspiration only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3rd generation dual-source CT</arm_group_label>
    <description>211 patients that have received a noncontrast-enhanced chest CT on our third generation dual-source CT scanner in inspiration and expiration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>computed tomography</intervention_name>
    <description>noncontrast-enhanced chest computed tomography</description>
    <arm_group_label>16-slice CT scanner</arm_group_label>
    <arm_group_label>2nd generation dual-source CT</arm_group_label>
    <arm_group_label>3rd generation dual-source CT</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The data was acquired retrospectively, by analyzing CT scans performed between August 2014
        and September 2017. Further, the three different study groups have retrospectively been
        matched using the water equivalent diameter (WED). A difference of 5% was desired to
        eliminate a size related bias in the effective organ dose calculation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  noncontrast-enhanced chest CT performed on one of the named devices

          -  imaging performed between August 2014 and September 2017

          -  CT protocol used as previously specified

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua FM Gawlitza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University medical center Mannheim</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Holger Haubenreisser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University medical center Mannheim</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederik Trinkmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University medical center Mannheim</affiliation>
  </overall_official>
  <reference>
    <citation>Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Crim C, Duvoix A, Fauerbach PN, Lomas DA, Macnee W, Mayer RJ, Miller BE, M체ller NL, Rennard SI, Silverman EK, Tal-Singer R, Wouters EF, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med. 2013 Apr;1(2):129-36. doi: 10.1016/S2213-2600(13)70006-7. Epub 2013 Feb 1.</citation>
    <PMID>24429093</PMID>
  </reference>
  <reference>
    <citation>Gawlitza J, Trinkmann F, Scheffel H, Fischer A, Nance JW, Henzler C, Vogler N, Saur J, Akin I, Borggrefe M, Schoenberg SO, Henzler T. Time to Exhale: Additional Value of Expiratory Chest CT in Chronic Obstructive Pulmonary Disease. Can Respir J. 2018 Mar 4;2018:9493504. doi: 10.1155/2018/9493504. eCollection 2018.</citation>
    <PMID>29686742</PMID>
  </reference>
  <reference>
    <citation>Haubenreisser H, Meyer M, Sudarski S, Allmendinger T, Schoenberg SO, Henzler T. Unenhanced third-generation dual-source chest CT using a tin filter for spectral shaping at 100kVp. Eur J Radiol. 2015 Aug;84(8):1608-1613. doi: 10.1016/j.ejrad.2015.04.018. Epub 2015 Apr 28.</citation>
    <PMID>26001437</PMID>
  </reference>
  <reference>
    <citation>Gordic S, Morsbach F, Schmidt B, Allmendinger T, Flohr T, Husarik D, Baumueller S, Raupach R, Stolzmann P, Leschka S, Frauenfelder T, Alkadhi H. Ultralow-dose chest computed tomography for pulmonary nodule detection: first performance evaluation of single energy scanning with spectral shaping. Invest Radiol. 2014 Jul;49(7):465-73. doi: 10.1097/RLI.0000000000000037.</citation>
    <PMID>24598443</PMID>
  </reference>
  <reference>
    <citation>Braun FM, Johnson TR, Sommer WH, Thierfelder KM, Meinel FG. Chest CT using spectral filtration: radiation dose, image quality, and spectrum of clinical utility. Eur Radiol. 2015 Jun;25(6):1598-606. doi: 10.1007/s00330-014-3559-1. Epub 2014 Dec 17.</citation>
    <PMID>25515204</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 22, 2018</study_first_submitted>
  <study_first_submitted_qc>July 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2018</study_first_posted>
  <last_update_submitted>July 6, 2018</last_update_submitted>
  <last_update_submitted_qc>July 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universit채tsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Joshua Gawlitza</investigator_full_name>
    <investigator_title>Head of COPD imaging research</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Computed tomography</keyword>
  <keyword>Expiration</keyword>
  <keyword>organ specific radiation dose</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

